Crystal structure of SARS-CoV-2 main protease in complex with protease inhibitor PF-07321332

被引:183
作者
Zhao, Yao [1 ,2 ]
Fang, Chao [3 ]
Zhang, Qi [1 ,2 ,4 ,5 ]
Zhang, Ruxue [6 ]
Zhao, Xiangbo [3 ]
Duan, Yinkai [1 ,2 ]
Wang, Haofeng [1 ,2 ]
Zhu, Yan [1 ,2 ]
Feng, Lu [1 ,2 ]
Zhao, Jinyi [1 ,2 ]
Shao, Maolin [1 ,2 ]
Yang, Xiuna [1 ,2 ]
Zhang, Leike [6 ]
Peng, Chao [7 ]
Yang, Kailin [8 ]
Ma, Dawei [3 ]
Rao, Zihe [1 ,2 ,9 ,10 ,11 ]
Yang, Haitao [1 ,2 ]
机构
[1] ShanghaiTech Univ, Shanghai Inst Adv Immunochem Studies, Shanghai 201210, Peoples R China
[2] ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai 201210, Peoples R China
[3] Univ Chinese Acad Sci, Chinese Acad Sci, State Key Lab Bioorgan & Nat Prod Chem, Ctr Excellence Mol Synth,Shanghai Inst Organ Chem, Shanghai 200032, Peoples R China
[4] Chinese Acad Sci, Shanghai Inst Biochem & Cell Biol, CAS Ctr Excellence Mol Cell Sci, Shanghai 200031, Peoples R China
[5] Univ Chinese Acad Sci, Beijing 100049, Peoples R China
[6] Chinese Acad Sci, Wuhan Inst Virol, Ctr Biosafety Mega Sci, State Key Lab Virol, Wuhan 430071, Peoples R China
[7] Chinese Acad Sci, Shanghai Adv Res Inst, Zhangjiang Lab, Natl Facil Prot Sci Shanghai, Shanghai 201210, Peoples R China
[8] Cleveland Clin, Taussig Canc Ctr, Cleveland, OH 44195 USA
[9] Tsinghua Univ, Sch Life Sci & Sch Med, Lab Struct Biol, Beijing 100091, Peoples R China
[10] Nankai Univ, State Key Lab Med Chem Biol, Coll Life Sci, Frontiers Sci Ctr Cell Response, Tianjin 300071, Peoples R China
[11] Tianjin Key Lab Prot Sci, Tianjin 300071, Peoples R China
基金
国家重点研发计划;
关键词
D O I
10.1007/s13238-021-00883-2
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
引用
收藏
页码:689 / 693
页数:5
相关论文
共 15 条
[1]  
Boras Britton, 2021, bioRxiv, DOI 10.1101/2020.09.12.293498
[2]   Recent Progress in the Drug Development Targeting SARS-CoV-2 Main Protease as Treatment for COVID-19 [J].
Cui, Wen ;
Yang, Kailin ;
Yang, Haitao .
FRONTIERS IN MOLECULAR BIOSCIENCES, 2020, 7
[3]   Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease [J].
Dai, Wenhao ;
Zhang, Bing ;
Jiang, Xia-Ming ;
Su, Haixia ;
Li, Jian ;
Zhao, Yao ;
Xie, Xiong ;
Jin, Zhenming ;
Peng, Jingjing ;
Liu, Fengjiang ;
Li, Chunpu ;
Li, You ;
Bai, Fang ;
Wang, Haofeng ;
Cheng, Xi ;
Cen, Xiaobo ;
Hu, Shulei ;
Yang, Xiuna ;
Wang, Jiang ;
Liu, Xiang ;
Xiao, Gengfu ;
Jiang, Hualiang ;
Rao, Zihe ;
Zhang, Lei-Ke ;
Xu, Yechun ;
Yang, Haitao ;
Liu, Hong .
SCIENCE, 2020, 368 (6497) :1331-+
[4]   Both Boceprevir and GC376 efficaciously inhibit SARS-CoV-2 by targeting its main protease [J].
Fu, Lifeng ;
Ye, Fei ;
Feng, Yong ;
Yu, Feng ;
Wang, Qisheng ;
Wu, Yan ;
Zhao, Cheng ;
Sun, Huan ;
Huang, Baoying ;
Niu, Peihua ;
Song, Hao ;
Shi, Yi ;
Li, Xuebing ;
Tan, Wenjie ;
Qi, Jianxun ;
Gao, George Fu .
NATURE COMMUNICATIONS, 2020, 11 (01)
[5]   Discovery of Ketone-Based Covalent Inhibitors of Coronavirus 3CL Proteases for the Potential Therapeutic Treatment of COVID-19 [J].
Hoffman, Robert L. ;
Kania, Robert S. ;
Brothers, Mary A. ;
Davies, Jay F. ;
Ferre, Rose A. ;
Gajiwala, Ketan S. ;
He, Mingying ;
Hogan, Robert J. ;
Kozminski, Kirk ;
Li, Lilian Y. ;
Lockner, Jonathan W. ;
Lou, Jihong ;
Marra, Michelle T. ;
Mitchell, Lennert J., Jr. ;
Murray, Brion W. ;
Nieman, James A. ;
Noell, Stephen ;
Planken, Simon P. ;
Rowe, Thomas ;
Ryan, Kevin ;
Smith, George J., III ;
Solowiej, James E. ;
Steppan, Claire M. ;
Taggart, Barbara .
JOURNAL OF MEDICINAL CHEMISTRY, 2020, 63 (21) :12725-12747
[6]   Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors [J].
Jin, Zhenming ;
Du, Xiaoyu ;
Xu, Yechun ;
Deng, Yongqiang ;
Liu, Meiqin ;
Zhao, Yao ;
Zhang, Bing ;
Li, Xiaofeng ;
Zhang, Leike ;
Peng, Chao ;
Duan, Yinkai ;
Yu, Jing ;
Wang, Lin ;
Yang, Kailin ;
Liu, Fengjiang ;
Jiang, Rendi ;
Yang, Xinglou ;
You, Tian ;
Liu, Xiaoce ;
Yang, Xiuna ;
Bai, Fang ;
Liu, Hong ;
Liu, Xiang ;
Guddat, Luke W. ;
Xu, Wenqing ;
Xiao, Gengfu ;
Qin, Chengfeng ;
Shi, Zhengli ;
Jiang, Hualiang ;
Rao, Zihe ;
Yang, Haitao .
NATURE, 2020, 582 (7811) :289-+
[7]   Resurgence of SARS-CoV-2 Infection in a Highly Vaccinated Health System Workforce [J].
Keehner, Jocelyn ;
Horton, Lucy E. ;
Binkin, Nancy J. ;
Laurent, Louise C. ;
Pride, David ;
Longhurst, Christopher A. ;
Abeles, Shira R. ;
Torriani, Francesca J. .
NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (14) :1330-1332
[8]   Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding [J].
Lu, Roujian ;
Zhao, Xiang ;
Li, Juan ;
Niu, Peihua ;
Yang, Bo ;
Wu, Honglong ;
Wang, Wenling ;
Song, Hao ;
Huang, Baoying ;
Zhu, Na ;
Bi, Yuhai ;
Ma, Xuejun ;
Zhan, Faxian ;
Wang, Liang ;
Hu, Tao ;
Zhou, Hong ;
Hu, Zhenhong ;
Zhou, Weimin ;
Zhao, Li ;
Chen, Jing ;
Meng, Yao ;
Wang, Ji ;
Lin, Yang ;
Yuan, Jianying ;
Xie, Zhihao ;
Ma, Jinmin ;
Liu, William J. ;
Wang, Dayan ;
Xu, Wenbo ;
Holmes, Edward C. ;
Gao, George F. ;
Wu, Guizhen ;
Chen, Weijun ;
Shi, Weifeng ;
Tan, Wenjie .
LANCET, 2020, 395 (10224) :565-574
[9]   Novel therapies for hepatitis C - one pill fits all? [J].
Manns, Michael P. ;
von Hahn, Thomas .
NATURE REVIEWS DRUG DISCOVERY, 2013, 12 (08) :595-610
[10]   Progress of the COVID-19 vaccine effort: viruses, vaccines and variants versus efficacy, effectiveness and escape [J].
Tregoning, John S. ;
Flight, Katie E. ;
Higham, Sophie L. ;
Wang, Ziyin ;
Pierce, Benjamin E. .
NATURE REVIEWS IMMUNOLOGY, 2021, 21 (10) :626-636